Journal of the American College of Cardiology
Volume 52, Issue 8 , Pages 644-651 , 19 August 2008

Lack of Association Between Adrenergic Receptor Genotypes and Survival in Heart Failure Patients Treated With Carvedilol or Metoprolol

  • Amy J. Sehnert, MD

      Affiliations

    • CardioDx, Inc., Palo Alto, California
    • Corresponding Author InformationReprint requests and correspondence: Dr. Amy J. Sehnert, CardioDx, Inc., 2500 Faber Place, Palo Alto, California 94303.
  • ,
  • Susan E. Daniels, PhD

      Affiliations

    • CardioDx, Inc., Palo Alto, California
  • ,
  • Michael Elashoff, PhD

      Affiliations

    • CardioDx, Inc., Palo Alto, California
  • ,
  • James A. Wingrove, PhD

      Affiliations

    • CardioDx, Inc., Palo Alto, California
  • ,
  • Christopher R. Burrow, MD

      Affiliations

    • CardioDx, Inc., Palo Alto, California
  • ,
  • Benjamin Horne, PhD

      Affiliations

    • Departments of Cardiology and Cardiovascular Research, Intermountain Medical Center, University of Utah, Salt Lake City, Utah
  • ,
  • Joseph B. Muhlestein, MD, FACC

      Affiliations

    • Departments of Cardiology and Cardiovascular Research, Intermountain Medical Center, University of Utah, Salt Lake City, Utah
  • ,
  • Mark Donahue, MD

      Affiliations

    • Department of Medicine and Cardiology, Duke University Medical Center, Durham, North Carolina
  • ,
  • Stephen B. Liggett, MD

      Affiliations

    • Departments of Medicine and Physiology, University of Maryland School of Medicine, Baltimore, Maryland.
  • ,
  • Jeffrey L. Anderson, MD, FACC

      Affiliations

    • Departments of Cardiology and Cardiovascular Research, Intermountain Medical Center, University of Utah, Salt Lake City, Utah
  • ,
  • William E. Kraus, MD, FACC

      Affiliations

    • Department of Medicine and Cardiology, Duke University Medical Center, Durham, North Carolina

Received 7 February 2008 ,Revised 29 April 2008 ,Accepted 5 May 2008.

References 

  1. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–e146
  2. McMurray JJ, Pfeffer MA. Heart failure. Lancet. 2005;365:1877–1889
  3. Morita H, Seidman J, Seidman CE. Genetic causes of human heart failure. J Clin Invest. 2005;115:518–526
  4. Donahue MP, Marchuk DA, Rockman HA. Redefining heart failure: the utility of genomics. J Am Coll Cardiol. 2006;48:1289–1298
  5. Tang WH, Francis GS. The year in heart failure. J Am Coll Cardiol. 2007;50:2344–2351
  6. Liggett SB. Pharmacogenetics of beta-1- and beta-2-adrenergic receptors. Pharmacology. 2000;61:167–173
  7. Small KM, McGraw DW, Liggett SB. Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol. 2003;43:381–411
  8. Feldman DS, Carnes CA, Abraham WT, Bristow MR. Mechanisms of disease: beta-adrenergic receptors—alterations in signal transduction and pharmacogenomics in heart failure. Nat Clin Pract Cardiovasc Med. 2005;2:475–483
  9. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001–2007
  10. Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002;106:2194–2199
  11. Muthumala A, Drenos F, Elliott PM, Humphries SE. Role of beta adrenergic receptor polymorphisms in heart failure: systematic review and meta-analysis. Eur J Heart Fail. 2008;10:3–13
  12. Shin J, Johnson JA. Pharmacogenetics of β-blockers. Pharmacotherapy. 2007;27:874–887
  13. Mason DA, Moore JD, Green SA, Liggett SB. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem. 1999;274:12670–12674
  14. de Groote P, Helbecque N, Lamblin N, et al. Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure. Pharmacogenet Genomics. 2005;15:137–142
  15. Kaye DM, Smirk B, Williams C, Jennings G, Esler M, Holst D. Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. Pharmacogenetics. 2003;13:379–382
  16. Liggett SB, Mialet-Perez J, Thaneemit-Chen S, et al. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failure. Proc Natl Acad Sci U S A. 2006;103:11288–11293
  17. Mialet Perez J, Rathz DA, Petrashevskaya NN, et al. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med. 2003;9:1300–1305
  18. Terra SG, Hamilton KK, Pauly DF, et al. Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to β-blocker therapy. Pharmacogenet Genomics. 2005;15:227–234
  19. Terra SG, Pauly DF, Lee CR, et al. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure. Clin Pharmacol Ther. 2005;77:127–137
  20. Morgan TM, Krumholz HM, Lifton RP, Spertus JA. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA. 2007;297:1551–1561
  21. Shin J, Lobmeyer MT, Gong Y, et al. Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure. Am J Cardiol. 2007;99:250–255
  22. Duke University School of Medicine, Division of Cardiovascular Medicine. Cardiovascular Genetic and Genomic Sciences. http://cardiology.duke.edu/modules/div_cv_rsch_cggs/Accessed December 2005 to July 2006
  23. ClinicalTrials.gov. Database Registry of the Intermountain Heart Collaborative Study. http://www.clinicaltrials.gov/ct2/show/NCT00406185?term=NCT00406185&rank=1Accessed April 2006 to July 2006
  24. The Social Security Death Master File. http://www.ssdmf.comAccessed March 2007
  25. Small KM, Mialet-Perez J, Seman CA, Theiss CT, Brown KM, Liggett SB. Polymorphisms of cardiac presynaptic alpha2C adrenergic receptors: diverse intragenic variability with haplotype-specific functional effects. Proc Natl Acad Sci U S A. 2004;101:13020–13025
  26. Dempster A, Laird N, Rubin D. Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc B. 1977;39:1–38
  27. Team RDC. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2007;
  28. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424–1433
  29. de Groote P, Lamblin N, Helbecque N, et al. The impact of beta-adrenoreceptor gene polymorphisms on survival in patients with congestive heart failure. Eur J Heart Fail. 2005;7:966–973
  30. White HL, de Boer RA, Maqbool A, et al. An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study. Eur J Heart Fail. 2003;5:463–468
  31. Tang WH, Tong W, Jain A, Francis GS, Harris CM, Young JB. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. J Am Coll Cardiol. 2008;51:569–576
  32. Hawkins GA, Tantisira K, Meyers DA, et al. Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study. Am J Respir Crit Care Med. 2006;174:1101–1109
  33. Small KM, Mialet-Perez J, Liggett SB. Genetic variation within the beta1-adrenergic receptor gene results in haplotype-specific expression phenotypes. J Cardiovasc Pharmacol. 2008;51:106–110

 Drs. Sehnert, Daniels, Elashoff, and Wingrove are paid employees of CardioDx, Inc. This work was funded by CardioDx, Inc.

PII: S0735-1097(08)01936-0

doi: 10.1016/j.jacc.2008.05.022

Journal of the American College of Cardiology
Volume 52, Issue 8 , Pages 644-651 , 19 August 2008